<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-500" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Papuloerythroderma of Ofuji</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lewis</surname>
            <given-names>Haley M.</given-names>
          </name>
          <aff>North Fulton</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shahsavari</surname>
            <given-names>Adam</given-names>
          </name>
          <aff>Larkin Community Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sathe</surname>
            <given-names>Nishad C.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Goodman</surname>
            <given-names>Marcus B.</given-names>
          </name>
          <aff>Philadelphia College of Osteopathic Med.</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Haley Lewis declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Adam Shahsavari declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nishad Sathe declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marcus Goodman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>7</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-500.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Papuloerythroderma of Ofuji is a rare skin disorder predominantly found in Japan. Characterized by polygonal, flat-topped erythematous-brown papules that coalesce into sheets that often cover the entire skin surface but spare the skin folds, this disorder poses diagnostic challenges. This activity explores the foundational diagnostic criteria established through meta-analysis, initially proposed by Torchia et al, comprising major and minor criteria pivotal in defining the condition and delineating its subtypes. With its discovery in 1984 by Ofuji, Furukawa, Miyachi, and Ohno, Papuloerythroderma of Ofuji commonly presents with pruritus, peripheral eosinophilia, and elevated immunoglobulin E (IgE) levels, necessitating a nuanced approach to diagnosis and management.</p>
        <p>This course discussion&#x000a0;underscores the interdisciplinary collaboration essential for effectively managing patients afflicted with Papuloerythroderma of Ofuji. Given the condition's rarity and potential resemblance to other dermatological and lymphoproliferative disorders, healthcare professionals will benefit from an in-depth understanding of the diagnostic criteria and differential diagnoses. By highlighting the role of an interprofessional team, this CME activity aims to enhance healthcare practitioners' proficiency in accurately diagnosing and managing Papuloerythroderma of Ofuji, thereby improving patient outcomes and ensuring appropriate therapeutic interventions.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the epidemiology of Papuloerythroderma of Ofuji.</p></list-item><list-item><p>Screen patients for Papuloerythroderma of Ofuji.</p></list-item><list-item><p>Compare the treatment and management options available for Papuloerythroderma of Ofuji.</p></list-item><list-item><p>Collaborate with the&#x000a0;interprofessional team to optimize care coordination and communication to advance the management of Papuloerythroderma of Ofuji and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=500&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=500">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-500.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Papuloerythroderma of Ofuji is a&#x000a0;rare skin disorder most commonly found in Japan. It is characterized by polygonal, flat-topped erythematous-brown papules coalescing into sheets&#x000a0;that often cover the entire skin surface but spare the skin folds.<xref ref-type="bibr" rid="article-500.r1">[1]</xref> Papuloerythroderma of Ofuji was first discovered in Japan in 1984 by Ofuji, Furukawa, Miyachi, and Ohno.<xref ref-type="bibr" rid="article-500.r2">[2]</xref> It is commonly accompanied by pruritus, peripheral eosinophilia, and elevated immunoglobulin E (IgE).<xref ref-type="bibr" rid="article-500.r3">[3]</xref></p>
        <p>The basis of the disease and initial diagnosis stems from an initial meta-analysis comprised of 170 patients via Torchia et al, who&#x000a0;proposed a preliminary set of&#x000a0;5 major and&#x000a0;5 minor criteria that define Papuloerythroderma of Ofuji.&#x000a0;These criteria help determine etiology and allow for categorization into&#x000a0;4 subtypes, which include primary, secondary,&#x000a0;and a nonpapular form of Papuloerythroderma of Ofuji.<xref ref-type="bibr" rid="article-500.r4">[4]</xref>&#x000a0;There is also a consideration for patients that appear clinically, like Papuloerythroderma of Ofuji, but have a diagnosis more consistent with lymphoma.<xref ref-type="bibr" rid="article-500.r5">[5]</xref></p>
      </sec>
      <sec id="article-500.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Although&#x000a0;the underlying etiology of Papuloerythroderma of Ofuji has not been elucidated, a clear connection between underlying malignancy, infectious processes, and pharmacological agents preceding the presentation of Papuloerythroderma of Ofuji has been a consistent theme.<xref ref-type="bibr" rid="article-500.r6">[6]</xref> The range of&#x000a0;oncologic disorders found in association with Papuloerythroderma of Ofuji includes gastric carcinomas, hepatocellular carcinoma, adenocarcinoma of the colon, cutaneous T-cell lymphoma, prostate cancer, and chronic lymphocytic leukemia; however, gastric adenocarcinoma has been noted to be the most common form of malignancy in a meta-analysis of cases of Papuloerythroderma of Ofuji.<xref ref-type="bibr" rid="article-500.r1">[1]</xref><xref ref-type="bibr" rid="article-500.r7">[7]</xref><xref ref-type="bibr" rid="article-500.r8">[8]</xref><xref ref-type="bibr" rid="article-500.r9">[9]</xref><xref ref-type="bibr" rid="article-500.r10">[10]</xref>&#x000a0;This&#x000a0;finding leads to the possibility of Papuloerythroderma of Ofuji being a paraneoplastic syndrome, with screening for underlying malignancy being a crucial component in the work-up of patients with Papuloerythroderma of Ofuji.<xref ref-type="bibr" rid="article-500.r11">[11]</xref></p>
        <p>In addition to&#x000a0;oncologic processes, the hepatitis C virus has also been found to cause Papuloerythroderma of Ofuji, with complete resolution of all lesions after the levels of hepatitis C viral antigen&#x000a0;become undetectable.<xref ref-type="bibr" rid="article-500.r12">[12]</xref>&#x000a0;Drug-induced Papuloerythroderma of Ofuji is a distinct T-helper cell type 2 (Th2)-mediated drug hypersensitivity, and the role of Th2 has been implicated in other associated with atopic disease.<xref ref-type="bibr" rid="article-500.r3">[3]</xref><xref ref-type="bibr" rid="article-500.r13">[13]</xref>&#x000a0;Pharmacological agents associated with this phenomenon include nicardipine, aspirin, isoniazid, furosemide, etretinate, ranitidine, leuprorelin, and diltiazem; interestingly, some of these medications, like etretinate, have been associated with the onset of Papuloerythroderma of Ofuji.<xref ref-type="bibr" rid="article-500.r13">[13]</xref></p>
      </sec>
      <sec id="article-500.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of Papuloerythroderma of Ofuji has been reported to be 1.5 cases per million; however, this is considered an underestimate since the condition is likely underdiagnosed.<xref ref-type="bibr" rid="article-500.r14">[14]</xref> The most common subset of the population affected by Papuloerythroderma of Ofuji consists&#x000a0;of those&#x000a0;55 years or older and of Asian or Caucasian descent.&#x000a0;There is&#x000a0;a predilection for males to females with a ratio of 4 to 1.<xref ref-type="bibr" rid="article-500.r1">[1]</xref></p>
        <p>Epidemiologic factors, including age and gender, comprise 2 of the&#x000a0;5 minor criteria for diagnosing Papuloerythroderma of Ofuji.<xref ref-type="bibr" rid="article-500.r4">[4]</xref>&#x000a0;The condition&#x000a0;is also commonly found in individuals with underlying cutaneous T-cell lymphoma (CTCL).<xref ref-type="bibr" rid="article-500.r5">[5]</xref><xref ref-type="bibr" rid="article-500.r15">[15]</xref>&#x000a0;This close correlation between the&#x000a0;2 diseases is a common theme and plays a significant role in evaluating Papuloerythroderma of Ofuji.<xref ref-type="bibr" rid="article-500.r16">[16]</xref></p>
      </sec>
      <sec id="article-500.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of&#x000a0;Papuloerythroderma of Ofuji remains unclear; however, multiple studies have shown it to be associated with malignancy, medications, infections, and atopic disease, with the resolution of the association generally linked with the cessation of&#x000a0;Papuloerythroderma of Ofuji symptoms.<xref ref-type="bibr" rid="article-500.r1">[1]</xref>&#x000a0;For malignancy, there is debate about whether it is a&#x000a0;paraneoplastic syndrome since it has been associated with malignancy in between 22% and 55% of cases.<xref ref-type="bibr" rid="article-500.r4">[4]</xref><xref ref-type="bibr" rid="article-500.r9">[9]</xref>&#x000a0;Because of its association with&#x000a0;a strong Th2 response, it has been postulated to arise in relation to atopic disease, allergies, or drug reactions.<xref ref-type="bibr" rid="article-500.r17">[17]</xref><xref ref-type="bibr" rid="article-500.r18">[18]</xref><xref ref-type="bibr" rid="article-500.r19">[19]</xref>&#x000a0;Infection has also been postulated as a preceding factor that causes an overactive immune system leading to this condition, but&#x000a0;this cause has only been found&#x000a0;in 4% of patients.<xref ref-type="bibr" rid="article-500.r4">[4]</xref><xref ref-type="bibr" rid="article-500.r20">[20]</xref> Most importantly, because Papuloerythroderma of Ofuji can be conflated with cutaneous lymphoma, particularly&#x000a0;CTCL and mycosis fungoides, it&#x000a0;has been proposed that its development has to do with an early stage of lymphoma.<xref ref-type="bibr" rid="article-500.r5">[5]</xref><xref ref-type="bibr" rid="article-500.r21">[21]</xref></p>
      </sec>
      <sec id="article-500.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histopathological examination of the&#x000a0;tissue&#x000a0;reveals focal hyperkeratosis and an acanthotic epidermis with some spongiosis.<xref ref-type="bibr" rid="article-500.r1">[1]</xref>&#x000a0;An inflammatory&#x000a0;infiltrate is present in a perivascular distribution with a nonspecific collection of plasma cells, eosinophils, macrophages, Langerhans cells, and lymphocytes with rare neutrophils; importantly, lymphocytes can demonstrate exocytosis but do not reveal epidermotropism, which would be more diagnostic for cutaneous lymphoma.<xref ref-type="bibr" rid="article-500.r1">[1]</xref> These findings are not pathognomonic; however, they aid in diagnosing and evaluating Papuloerythroderma of Ofuji.<xref ref-type="bibr" rid="article-500.r10">[10]</xref><xref ref-type="bibr" rid="article-500.r22">[22]</xref></p>
      </sec>
      <sec id="article-500.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Included in the history and physical of a patient with suspected Papuloerythroderma of Ofuji, the provider should elucidate the presence of pruritus, establish the status of atopy, and exclude all external triggering factors, including atopy, infectious processes, malignancy (including CTCL), and drug-induced lesions, per&#x000a0;the major criteria for diagnosing&#x000a0;Papuloerythroderma of Ofuji.<xref ref-type="bibr" rid="article-500.r1">[1]</xref>&#x000a0;</p>
        <p>The minor criteria for diagnosing Papuloerythroderma of Ofuji include age over 55, male sex, peripheral eosinophilia, elevated serum IgE, and reduced lymphocyte count.<xref ref-type="bibr" rid="article-500.r1">[1]</xref><xref ref-type="bibr" rid="article-500.r4">[4]</xref>&#x000a0;A full-body skin examination will likely reveal erythematous lesions comprised of flat, confluent, reddish-brown papules with distribution on the&#x000a0;trunk, extremities, and extensor surfaces. In addition to these lesions, a positive deck-chair sign should be present, defined by the exclusion of inframammary folds, axillary folds, inguinal creases, and popliteal fossae.<xref ref-type="bibr" rid="article-500.r23">[23]</xref>&#x000a0;Other findings may include palmoplantar keratoderma and lymphadenopathy, which may raise suspicion of malignancy.<xref ref-type="bibr" rid="article-500.r1">[1]</xref> Dermoscopy of Papuloerythroderma of Ofuji reveals multiple erythematous pinpoint papules with surrounding whitish halos on an erythematous-pinkish background.<xref ref-type="bibr" rid="article-500.r16">[16]</xref></p>
      </sec>
      <sec id="article-500.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Laboratory, histopathological, and clinical features are the hallmarks of the evaluation of Papuloerythroderma of Ofuji through the major and minor criteria. However, the disease is a diagnosis of exclusion after excluding other causes of erythroderma (eg, atopic dermatitis, psoriasis, malignancy, cutaneous T-cell lymphoma, etc).<xref ref-type="bibr" rid="article-500.r1">[1]</xref> Laboratory tests, including complete blood count, comprehensive metabolic panel, serum IgE, and titers for Epstein-Barr virus, cytomegalovirus, hepatitis B virus, hepatitis C virus, and HIV should be performed; testing for syphilis, including rapid plasma reagin and venereal diseases reference laboratory tests should be performed.<xref ref-type="bibr" rid="article-500.r1">[1]</xref>&#x000a0;</p>
        <p>The presence of lymphopenia, elevated serum IgE, and peripheral eosinophilia are consistent with the diagnosis of Papuloerythroderma of Ofuji.<xref ref-type="bibr" rid="article-500.r1">[1]</xref> Histological evaluation of a punch biopsy should be performed in patients. Due to the similarity in the clinical presentation of CTCL and that of Papuloerythroderma of Ofuji, patients should undergo flow cytometry and T-cell receptor clonality studies to rule out the possibility of misdiagnosis and to prevent further delay of treatment in patients with CTCL.<xref ref-type="bibr" rid="article-500.r5">[5]</xref>&#x000a0;Further studies have indicated that testing for thymus and activation-regulated chemokine (TARC) may be a diagnostic marker that could help tailor treatment.<xref ref-type="bibr" rid="article-500.r1">[1]</xref><xref ref-type="bibr" rid="article-500.r3">[3]</xref>&#x000a0;One study suggested obtaining PET scans to rule out malignancy.<xref ref-type="bibr" rid="article-500.r1">[1]</xref><xref ref-type="bibr" rid="article-500.r24">[24]</xref><xref ref-type="bibr" rid="article-500.r25">[25]</xref></p>
      </sec>
      <sec id="article-500.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of Papuloerythroderma of Ofuji initially consists of finding the underlying etiology and treating the&#x000a0;secondary disease.&#x000a0;This&#x000a0;step may include the treatment of infectious processes or the removal of pharmacological agents.<xref ref-type="bibr" rid="article-500.r1">[1]</xref><xref ref-type="bibr" rid="article-500.r20">[20]</xref>&#x000a0;For cases of idiopathic disease, there is no gold standard of therapy; however,&#x000a0; cases have been treated with photochemotherapy (psoralen&#x000a0;plus&#x000a0;ultraviolet&#x000a0;A [PUVA]-psoralen and ultraviolet A),&#x000a0;topical corticosteroids, methotrexate, azathioprine, interferon alfa, etretinate,&#x000a0;and cyclosporine.<xref ref-type="bibr" rid="article-500.r1">[1]</xref><xref ref-type="bibr" rid="article-500.r26">[26]</xref><xref ref-type="bibr" rid="article-500.r27">[27]</xref><xref ref-type="bibr" rid="article-500.r28">[28]</xref><xref ref-type="bibr" rid="article-500.r29">[29]</xref><xref ref-type="bibr" rid="article-500.r30">[30]</xref><xref ref-type="bibr" rid="article-500.r31">[31]</xref></p>
        <p>Wet wraps and oral antihistamines have been shown as treatments in&#x000a0;2 cases.<xref ref-type="bibr" rid="article-500.r32">[32]</xref>&#x000a0;Additionally, A 9-month course of cyclosporine at 3 mg/kg was noted to lead to complete resolution of skin lesions with some residual postinflammatory change.<xref ref-type="bibr" rid="article-500.r13">[13]</xref><xref ref-type="bibr" rid="article-500.r22">[22]</xref>&#x000a0;Because of a suggested Th2-based etiology of&#x000a0;Papuloerythroderma of Ofuji, newer studies have suggested treatment with dupilumab; however, this may need to be used cautiously after a&#x000a0;complete workup for malignancy.<xref ref-type="bibr" rid="article-500.r19">[19]</xref><xref ref-type="bibr" rid="article-500.r33">[33]</xref><xref ref-type="bibr" rid="article-500.r34">[34]</xref><xref ref-type="bibr" rid="article-500.r35">[35]</xref></p>
      </sec>
      <sec id="article-500.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of Papuloerythroderma of Ofuji should include CTCL, secondary syphilis, and drug reaction with eosinophilia and systemic symptoms (DRESS).<xref ref-type="bibr" rid="article-500.r1">[1]</xref><xref ref-type="bibr" rid="article-500.r21">[21]</xref><xref ref-type="bibr" rid="article-500.r25">[25]</xref>&#x000a0;CTCL and Papuloerythroderma of Ofuji can be differentiated through&#x000a0;flow cytometry and evaluation of clonal T-cell samples; secondary syphilis may be ruled out via VDRL and RPR testing; and&#x000a0;DRESS can be differentiated via its acute presentation versus the more gradual, chronic, and indolent course of Papuloerythroderma of Ofuji.<xref ref-type="bibr" rid="article-500.r13">[13]</xref>&#x000a0;There is a wide differential of diseases associated with the deck-chair sign since this is not specific to&#x000a0;Papuloerythroderma of Ofuji; the differential can include psoriasis, atopic or contact dermatitis, lymphoma, acanthosis nigricans, and drug eruptions.<xref ref-type="bibr" rid="article-500.r1">[1]</xref></p>
      </sec>
      <sec id="article-500.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The course of Papuloerythroderma of Ofuji is generally indolent, with remission occurring many years after the initial onset in idiopathic cases.<xref ref-type="bibr" rid="article-500.r23">[23]</xref> Those with secondary etiology leading to Papuloerythroderma of Ofuji may experience rapid clearance of lesions upon removing the offending agents or treating the underlying causes.<xref ref-type="bibr" rid="article-500.r1">[1]</xref><xref ref-type="bibr" rid="article-500.r36">[36]</xref>&#x000a0;Without secondary bacterial superinfection, the overall disease progression is nonacute and consists of resolving pruritus, which generally leads to complete resolution.<xref ref-type="bibr" rid="article-500.r37">[37]</xref>&#x000a0;It has been noted that the course of&#x000a0;Papuloerythroderma of Ofuji is approximately 7 months, but it is expected to be a chronic and indolent skin disease.<xref ref-type="bibr" rid="article-500.r1">[1]</xref>&#x000a0;The association of&#x000a0;Papuloerythroderma of Ofuji with atopic disease and malignancy is notable, with one study reporting atopic disease in 20% of patients and reporting malignancy in 22%-55% of patients.<xref ref-type="bibr" rid="article-500.r1">[1]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-500.s12" sec-type="Complications">
        <title>Complications</title>
        <p>A significant complication of Papuloerythroderma of Ofuji is secondary bacterial superinfection of the polygonal papular lesions, likely due to excoriation.<xref ref-type="bibr" rid="article-500.r1">[1]</xref><xref ref-type="bibr" rid="article-500.r4">[4]</xref> These secondary infections may lead to erysipelas or cellulitis, significantly impacting patients' overall well-being. These complications are manageable with brief oral courses of clindamycin or cefuroxime.<xref ref-type="bibr" rid="article-500.r22">[22]</xref> In addition to bacterial superinfection, a delay in diagnosis of CTCL can also occur if there is a diagnosis of Papuloerythroderma of Ofuji without proper evaluation to rule out CTCL.<xref ref-type="bibr" rid="article-500.r5">[5]</xref>&#x000a0;It is unclear if lymphoma is an eventual outcome of&#x000a0;Papuloerythroderma of Ofuji or if it is a similar diagnosis; for conservative measures, it may be most appropriate to monitor the patient for the development of signs of lymphoma as some have proposed that&#x000a0;Papuloerythroderma of Ofuji is a precursor to mycosis fungoides.<xref ref-type="bibr" rid="article-500.r1">[1]</xref><xref ref-type="bibr" rid="article-500.r21">[21]</xref><xref ref-type="bibr" rid="article-500.r38">[38]</xref></p>
      </sec>
      <sec id="article-500.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients suffering from Papuloerythroderma of Ofuji should receive proper education on the correlations between Papuloerythroderma of Ofuji and multiple internal malignancies, as well as its similarity and possible association with CTCL. Proper screening and evaluation to rule out these internal malignancies are crucial components in the management of Papuloerythroderma of Ofuji, and informing patients regarding the types of screening they should undergo will aid in the adequate evaluation of possible underlying disease processes.</p>
      </sec>
      <sec id="article-500.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of Papuloerythroderma of Ofuji requires the participation of an interprofessional healthcare team approach.&#x000a0;Aside from the primary care provider, nurse practitioner, and internist, the involvement of specialists in multiple fields to aid in diagnosing underlying malignancy should have participation at an early stage in the disease process. Pharmacists can be integral in helping determine when the condition is drug-induced, as well as providing recommendations for pharmaceutical therapy. Nursing is often the primary point of contact for patients and families, providing education.</p>
        <p>Patients with Papuloerythroderma of Ofuji should undergo evaluation via a gastroenterologist to perform upper endoscopy and colonoscopy to rule out gastric carcinoma and adenocarcinoma of the colon. In addition to proper gastroenterological work-up, patients should be evaluated for any hematological abnormalities and referred to hematology&#x000a0;and oncology specialists if any cell line abnormalities, flow cytometry abnormalities, or clinical features of malignancy are present.<xref ref-type="bibr" rid="article-500.r7">[7]</xref><xref ref-type="bibr" rid="article-500.r8">[8]</xref><xref ref-type="bibr" rid="article-500.r9">[9]</xref><xref ref-type="bibr" rid="article-500.r10">[10]</xref></p>
      </sec>
      <sec id="article-500.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=500&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=500">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/papuloerythroderma-of-ofuji/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=500">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/500/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=500">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-500.s16">
        <fig id="article-500.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Papuloerythroderma of Ofuji, rash, skin folds StatPearls Publishing Illustration</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Ofuji" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-500.s17">
        <title>References</title>
        <ref id="article-500.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Desai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Miteva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Romanelli</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Papuloerythroderma of Ofuji.</article-title>
            <source>Clin Dermatol</source>
            <year>2021</year>
            <season>Mar-Apr</season>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>248</fpage>
            <page-range>248-255</page-range>
            <pub-id pub-id-type="pmid">34272018</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allegue</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fachal</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Vilas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zulaica</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Papuloerythroderma of Ofuji successfully treated with methotrexate.</article-title>
            <source>Dermatol Ther</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>e12638</fpage>
            <pub-id pub-id-type="pmid">30019369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Teraki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Skin-homing Th2/Th22 cells in papuloerythroderma of Ofuji.</article-title>
            <source>Dermatology</source>
            <year>2014</year>
            <volume>228</volume>
            <issue>4</issue>
            <fpage>326</fpage>
            <page-range>326-31</page-range>
            <pub-id pub-id-type="pmid">24732450</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Torchia</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Miteva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Romanelli</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Papuloerythroderma 2009: two new cases and systematic review of the worldwide literature 25 years after its identification by Ofuji et al.</article-title>
            <source>Dermatology</source>
            <year>2010</year>
            <volume>220</volume>
            <issue>4</issue>
            <fpage>311</fpage>
            <page-range>311-20</page-range>
            <pub-id pub-id-type="pmid">20339287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maher</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Glassman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Litvinov</surname>
                <given-names>IV</given-names>
              </name>
            </person-group>
            <article-title>The Importance of Excluding Cutaneous T-Cell Lymphomas in Patients with a Working Diagnosis of Papuloerythroderma of Ofuji: A Case Series.</article-title>
            <source>Case Rep Dermatol</source>
            <year>2018</year>
            <season>Jan-Apr</season>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>46</fpage>
            <page-range>46-54</page-range>
            <pub-id pub-id-type="pmid">29606946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khoschbin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>L&#x000f6;ser</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dippel</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>[Paraneoplastic skin diseases].</article-title>
            <source>Internist (Berl)</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>60</volume>
            <issue>8</issue>
            <fpage>775</fpage>
            <page-range>775-782</page-range>
            <pub-id pub-id-type="pmid">31273399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hara</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Takayanagi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Terui</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Coexistence of papuloerythroderma of Ofuji and acrokeratosis paraneoplastica (Bazex syndrome) preceding the diagnosis of primary hepatocellular carcinoma.</article-title>
            <source>Int J Dermatol</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>50</volume>
            <issue>11</issue>
            <fpage>1393</fpage>
            <page-range>1393-1396</page-range>
            <pub-id pub-id-type="pmid">22004495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salg&#x000fc;ero</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Aguayo-Leiva</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Harto</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Papuloerythroderma of Ofuji associated with chronic lymphatic leukaemia.</article-title>
            <source>Eur J Dermatol</source>
            <year>2009</year>
            <season>Jul-Aug</season>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>396</fpage>
            <page-range>396-7</page-range>
            <pub-id pub-id-type="pmid">19467967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Teraki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Aso</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>High incidence of internal malignancy in papuloerythroderma of Ofuji: a case series from Japan.</article-title>
            <source>Dermatology</source>
            <year>2012</year>
            <volume>224</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-9</page-range>
            <pub-id pub-id-type="pmid">22327542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schepers</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Malvehy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Az&#x000f3;n-Masoliver</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Navarra</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ferrando</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mascar&#x000f3;</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Papuloerythroderma of Ofuji: a report of 2 cases including the first European case associated with visceral carcinoma.</article-title>
            <source>Dermatology</source>
            <year>1996</year>
            <volume>193</volume>
            <issue>2</issue>
            <fpage>131</fpage>
            <page-range>131-5</page-range>
            <pub-id pub-id-type="pmid">8884150</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wick</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Patterson</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous paraneoplastic syndromes.</article-title>
            <source>Semin Diagn Pathol</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>211</fpage>
            <page-range>211-228</page-range>
            <pub-id pub-id-type="pmid">30736994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ota</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sato-Matsumura</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Sawamura</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Papuloerythroderma associated with hepatitis C virus infection.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>52</volume>
            <issue>2 Suppl 1</issue>
            <fpage>61</fpage>
            <page-range>61-2</page-range>
            <pub-id pub-id-type="pmid">15692520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sugita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kabashima</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tokura</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced papuloerythroderma: analysis of T-cell populations and a literature review.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>89</volume>
            <issue>6</issue>
            <fpage>618</fpage>
            <page-range>618-22</page-range>
            <pub-id pub-id-type="pmid">19997694</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bech-Thomsen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Thomsen</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Ofuji's papuloerythroderma: a study of 17 cases.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>1998</year>
            <month>Mar</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>79</fpage>
            <page-range>79-83</page-range>
            <pub-id pub-id-type="pmid">9692312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jahan-Tigh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Duvic</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Papuloerythroderma of Ofuji associated with an indolent CD3(-), CD4(+), TCR(-) peripheral T-cell lymphoma.</article-title>
            <source>Leuk Lymphoma</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>54</volume>
            <issue>9</issue>
            <fpage>2059</fpage>
            <page-range>2059-61</page-range>
            <pub-id pub-id-type="pmid">23294328</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Apalla</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Koukouthaki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sidiropoulos</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Psarakis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nikolaidou</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bobos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kampouropoulou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lallas</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Dermoscopy of papuloerythroderma of Ofuji.</article-title>
            <source>Photodermatol Photoimmunol Photomed</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>127</fpage>
            <page-range>127-128</page-range>
            <pub-id pub-id-type="pmid">30472755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pullmann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Luger</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Metze</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>[Papuloerythroderma of Ofuji with urticarial lesions].</article-title>
            <source>J Dtsch Dermatol Ges</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>2</volume>
            <issue>6</issue>
            <fpage>443</fpage>
            <page-range>443-7</page-range>
            <pub-id pub-id-type="pmid">16281602</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Camacho</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Hernandez</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz-P&#x000e9;rez</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Mazuecos</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sotillo</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Ofuji papuloerythroderma in an elderly woman with atopic erythroderma.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2001</year>
            <month>May</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>264</fpage>
            <page-range>264-6</page-range>
            <pub-id pub-id-type="pmid">11683297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hendricks</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Yosipovitch</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>VY</given-names>
              </name>
            </person-group>
            <article-title>Dupilumab use in dermatologic conditions beyond atopic dermatitis - a systematic review.</article-title>
            <source>J Dermatolog Treat</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-28</page-range>
            <pub-id pub-id-type="pmid">31693426</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hasegawa</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Tachibana</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Toma</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Papuloerythroderma of Ofuji associated with strongyloidiasis.</article-title>
            <source>J Dermatol</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>157</fpage>
            <page-range>157-8</page-range>
            <pub-id pub-id-type="pmid">12692386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nashan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Faulhaber</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>St&#x000e4;nder</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Luger</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Stadler</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Mycosis fungoides: a dermatological masquerader.</article-title>
            <source>Br J Dermatol</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>156</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-10</page-range>
            <pub-id pub-id-type="pmid">17199560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terlikowska-Brz&#x000f3;sko</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paluchowska</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Owczarek</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Majewski</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Papuloerythroderma of Ofuji in a 41-year-old woman.</article-title>
            <source>Postepy Dermatol Alergol</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>324</fpage>
            <page-range>324-8</page-range>
            <pub-id pub-id-type="pmid">24353495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ofuji</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Furukawa</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Miyachi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ohno</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Papuloerythroderma.</article-title>
            <source>Dermatologica</source>
            <year>1984</year>
            <volume>169</volume>
            <issue>3</issue>
            <fpage>125</fpage>
            <page-range>125-30</page-range>
            <pub-id pub-id-type="pmid">6148269</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>18F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography in symmetrically enlarged axillary and inguinal lymph nodes of Ofuji's papuloerythroderma.</article-title>
            <source>Leuk Lymphoma</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>53</volume>
            <issue>3</issue>
            <fpage>511</fpage>
            <page-range>511-3</page-range>
            <pub-id pub-id-type="pmid">21867461</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>MMF</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HY</given-names>
              </name>
            </person-group>
            <article-title>Papuloerythroderma of Ofuji presenting as a paraneoplastic phenomenon in myelodysplastic syndrome.</article-title>
            <source>Australas J Dermatol</source>
            <year>2018</year>
            <month>May</month>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>e155</fpage>
            <page-range>e155-e156</page-range>
            <pub-id pub-id-type="pmid">28771683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kasai</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Habe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Matsushima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kondo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamanaka</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Papuloerythroderma of Ofuji associated with sternoclavicular arthritis and successful treatment with cyclosporine.</article-title>
            <source>JAAD Case Rep</source>
            <year>2022</year>
            <month>Sep</month>
            <volume>27</volume>
            <fpage>70</fpage>
            <page-range>70-74</page-range>
            <pub-id pub-id-type="pmid">35990234</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balestri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Magnano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rech</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zorzi</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Girardelli</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Long-term use of methotrexate in Papuloerythroderma of Ofuji.</article-title>
            <source>Dermatol Ther</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>e13219</fpage>
            <pub-id pub-id-type="pmid">31912936</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qureshi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Natkunarajah</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Methotrexate for papuloerythroderma of Ofuji.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>45</volume>
            <issue>2</issue>
            <fpage>241</fpage>
            <page-range>241-243</page-range>
            <pub-id pub-id-type="pmid">31111514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qu&#x000e9;m&#x000e9;neur</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ghislain</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Morant</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Devis</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Creuzy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Modiano</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>[Ofuji's papuloerythroderma: two cases treated with azathioprine].</article-title>
            <source>Ann Dermatol Venereol</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>129</volume>
            <issue>2</issue>
            <fpage>213</fpage>
            <page-range>213-5</page-range>
            <pub-id pub-id-type="pmid">11937960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mutluer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yerebakan</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Alpsoy</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ciftcioglu</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Yilmaz</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Treatment of papuloerythroderma of Ofuji with Re-PUVA: a case report and review of the therapy.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>480</fpage>
            <page-range>480-3</page-range>
            <pub-id pub-id-type="pmid">15196168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fujii</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kanno</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ohgo</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Etretinate therapy for papuloerythroderma.</article-title>
            <source>Eur J Dermatol</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>8</issue>
            <fpage>610</fpage>
            <page-range>610-3</page-range>
            <pub-id pub-id-type="pmid">10586126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Wet-wrap therapy combined with compound glycyrrhizin and oral antihistamines as a therapy option for two cases of papuloerythroderma of ofuji.</article-title>
            <source>Dermatol Ther</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>35</volume>
            <issue>11</issue>
            <fpage>e15852</fpage>
            <pub-id pub-id-type="pmid">36153613</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Komatsu-Fujii</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nonoyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ogawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fukumoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tanabe</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Rapid effects of dupilumab treatment on papuloerythroderma of Ofuji.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>34</volume>
            <issue>11</issue>
            <fpage>e739</fpage>
            <page-range>e739-e741</page-range>
            <pub-id pub-id-type="pmid">32379915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Teraki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Taguchi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Takamura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fukuda</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Use of Dupilumab in the Treatment of Papuloerythroderma of Ofuji.</article-title>
            <source>JAMA Dermatol</source>
            <year>2019</year>
            <month>Aug</month>
            <day>01</day>
            <volume>155</volume>
            <issue>8</issue>
            <fpage>979</fpage>
            <page-range>979-980</page-range>
            <pub-id pub-id-type="pmid">31215964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schaefer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Comfere</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sokumbi</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Development of Cutaneous T-Cell Lymphoma Following Biologic Treatment: A Systematic Review.</article-title>
            <source>Am J Clin Dermatol</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>153</fpage>
            <page-range>153-164</page-range>
            <pub-id pub-id-type="pmid">36627479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dwyer</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>GD</given-names>
              </name>
            </person-group>
            <article-title>Papuloerythroderma and cutaneous T cell lymphoma.</article-title>
            <source>Dermatology</source>
            <year>1994</year>
            <volume>188</volume>
            <issue>4</issue>
            <fpage>326</fpage>
            <page-range>326-8</page-range>
            <pub-id pub-id-type="pmid">8193409</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Az&#x000f3;n-Masoliver</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Casad&#x000f3;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Brunet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>del Castillo</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Ofuji's papuloerythroderma following choledocholithiasis with secondary sepsis: complete resolution with surgery.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>1998</year>
            <month>Mar</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>84</fpage>
            <page-range>84-6</page-range>
            <pub-id pub-id-type="pmid">9692313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-500.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Fagan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chitnavis</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Grider</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Papuloerythroderma of Ofuji in a Young Man.</article-title>
            <source>Cureus</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>e36598</fpage>
            <pub-id pub-id-type="pmid">37095814</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
